Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply

JAMA Ophthalmol. 2023 Apr 1;141(4):408-409. doi: 10.1001/jamaophthalmol.2023.0009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Hypertension, Pulmonary* / etiology
  • Infant, Newborn
  • Infant, Premature
  • Intercellular Signaling Peptides and Proteins / therapeutic use
  • Intravitreal Injections
  • Retinopathy of Prematurity* / complications
  • Retinopathy of Prematurity* / diagnosis
  • Retinopathy of Prematurity* / drug therapy

Substances

  • Angiogenesis Inhibitors
  • Intercellular Signaling Peptides and Proteins
  • Bevacizumab